The CheXbert labeler accurately detects the presence or absence of 14 common medical conditions in radiology reports, converting unstructured radiology text into a structured format.
Derek F. Amanatullah and his research group developed an instrumented retractor that was designed to record the applied force, duration, and angle of retraction during a piriformis-sparing posterior approach to the hip.
Stanford researchers have developed a library of polymeric hydrogel formulations to prevent and/or reduce biofouling on implanted sensors and medical devices.
The Murmann lab has developed a method for an extraction information from acoustic signals that utilizes low power consumption. N-path filters are used to decompose the original acoustic signals' waveform before downconverting to lower their Nyquist-rate bandwidth.
Researchers in the Dionne group at Stanford have designed a nanoscale laser capable of self-isolated Raman Lasing, where lasing and isolation occurs within the same pumping mechanism.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an efficacious therapy for patients with life-threatening leukemias, but its use has been hindered by the limited availability of donors with matching HLA. Graft manipulation by removing ??
Researchers in Prof. Karl Deisseroth's laboratory have combined optogenetics with functional magnetic resonance imaging (fMRI) to enable highly specific in vivo analysis of brain circuits.
Researchers in Prof. Karl Deisseroth's laboratory have used optogenetic tools to develop an animal model for cocaine-modulated behavior modification by precisely targeting defined neural circuit elements.
Researchers in the laboratories of Dr. Karl Deisseroth and Dr. Peter Hegemann have engineered mutant ChR2 (Channelrhodopsin-2) proteins with light-sensitivity that is increased by orders of magnitude compared to wild-type ChR2.
Researchers in Prof. Karl Deisseroth's lab have discovered and engineered new microbial opsin proteins and cell trafficking tools to enable selective cell-type specific, light-sensitive switches for neuromodulation.
Researchers from Prof. Karl Deisseroth's laboratory have developed techniques for specifically modulating the activity of excitable cells in vivo. This approach introduces light-responsive proteins to create photo-sensitive cells.
Researchers in Dr. Karl Deisseroth's laboratory at Stanford University have developed a novel suite of genetically-encodable, optically-activated modulators of second messengers (such as cAMP and IP3).
The inventors have developed a light-driven chloride pump (NpHR or Halo) for temporally precise optical inhibition of neural activity with ordinary yellow light.